Schroder Investment Management Group Lowers Position in iRhythm Technologies, Inc. (NASDAQ:IRTC)

Schroder Investment Management Group lessened its holdings in iRhythm Technologies, Inc. (NASDAQ:IRTC - Free Report) by 5.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 308,338 shares of the company's stock after selling 18,062 shares during the quarter. Schroder Investment Management Group owned 0.99% of iRhythm Technologies worth $27,803,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in IRTC. Homestead Advisers Corp grew its stake in shares of iRhythm Technologies by 31.9% during the 4th quarter. Homestead Advisers Corp now owns 28,100 shares of the company's stock worth $2,534,000 after purchasing an additional 6,800 shares during the period. EFG Asset Management North America Corp. boosted its holdings in iRhythm Technologies by 113.6% during the fourth quarter. EFG Asset Management North America Corp. now owns 28,430 shares of the company's stock worth $2,565,000 after buying an additional 15,118 shares in the last quarter. Segall Bryant & Hamill LLC grew its position in iRhythm Technologies by 5.1% during the fourth quarter. Segall Bryant & Hamill LLC now owns 139,391 shares of the company's stock worth $12,569,000 after buying an additional 6,789 shares during the period. Vanguard Group Inc. increased its holdings in iRhythm Technologies by 0.6% in the fourth quarter. Vanguard Group Inc. now owns 3,136,370 shares of the company's stock valued at $282,806,000 after buying an additional 18,442 shares in the last quarter. Finally, LPL Financial LLC acquired a new stake in shares of iRhythm Technologies during the 4th quarter valued at approximately $243,000.

iRhythm Technologies Trading Down 0.2 %

Shares of IRTC traded down $0.17 on Monday, hitting $100.17. 546,918 shares of the stock traded hands, compared to its average volume of 454,879. iRhythm Technologies, Inc. has a 1 year low of $55.92 and a 1 year high of $128.52. The stock's 50 day moving average is $107.40 and its two-hundred day moving average is $91.47. The firm has a market capitalization of $3.15 billion, a P/E ratio of -27.52 and a beta of 1.45. The company has a quick ratio of 6.12, a current ratio of 6.27 and a debt-to-equity ratio of 9.00.

iRhythm Technologies (NASDAQ:IRTC - Get Free Report) last issued its quarterly earnings results on Thursday, February 20th. The company reported $0.01 earnings per share for the quarter, topping analysts' consensus estimates of ($0.29) by $0.30. The company had revenue of $164.33 million for the quarter, compared to analyst estimates of $158.30 million. iRhythm Technologies had a negative return on equity of 118.83% and a negative net margin of 19.14%. As a group, sell-side analysts predict that iRhythm Technologies, Inc. will post -1.98 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on IRTC shares. The Goldman Sachs Group raised their price objective on iRhythm Technologies from $91.00 to $124.00 and gave the company a "neutral" rating in a research note on Monday, February 24th. Canaccord Genuity Group raised their price target on iRhythm Technologies from $125.00 to $152.00 and gave the company a "buy" rating in a research report on Monday, December 9th. Truist Financial boosted their price objective on shares of iRhythm Technologies from $111.00 to $145.00 and gave the stock a "buy" rating in a research report on Friday, February 21st. Wells Fargo & Company raised their target price on shares of iRhythm Technologies from $86.00 to $104.00 and gave the company an "equal weight" rating in a report on Friday, February 21st. Finally, Oppenheimer lifted their target price on shares of iRhythm Technologies from $105.00 to $120.00 and gave the stock an "outperform" rating in a research report on Wednesday, January 8th. Three research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat, iRhythm Technologies currently has a consensus rating of "Moderate Buy" and a consensus price target of $119.73.

iRhythm Technologies Company Profile

iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.